Additional file 2 of Evaluation and limitations of different approaches among COVID-19 fatal cases using whole-exome sequencing data

Additional file 2: Table S2. All 900 Covid-19 associated risk variants used in our analyses with Fisher's exact test p-values. • /p-value - included in the analysis; sig - significance: * - p-value < 0.05, ** - significant after Bonferroni correction; # - overlap with risk variants from QCI infection group; § - overlap with risk variants from QCI critical group; sN - Slovak NIPT data, W - WES data of Slovak dead patients, N - non-Finnish European gnomAD data.

附加文件2：表S2。本研究分析中使用的全部900个新型冠状病毒肺炎（COVID-19）相关风险变异及其费希尔精确检验（Fisher's exact test）P值。
• /p-value：纳入本次分析；
• sig：显著性标记：*代表P值<0.05，**代表经邦费罗尼校正（Bonferroni correction）后仍具有统计学显著性；
• #：与QCI感染组的风险变异存在重叠；
• §：与QCI重症组的风险变异存在重叠；
• sN：斯洛伐克无创产前基因检测（Non-Invasive Prenatal Testing, NIPT）数据集；W：斯洛伐克已故患者的全外显子组测序（Whole Exome Sequencing, WES）数据集；N：非芬兰欧洲裔gnomAD数据集。